Skip to main navigation Skip to search Skip to main content

A Phase 1, Open-label Study to Evaluate the Safety, Pharmacokinetics and Anti-Tumor Activity of Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer

Project: Research

Project Details

StatusActive
Effective start/end date03/2/22 → 01/8/27

Funding

  • ESSA Pharma: $101,730.00